Press release
Rising Obesity Rates Fuel Growth In Cardiometabolic Disease Market: Key Factor Driving The Growth In The Cardiometabolic Diseases Market
Cardiometabolic Diseases
What Is the Expected Cardiometabolic Diseases Market Size During the Forecast Period?
The Cardiometabolic Diseases Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Cardiometabolic Diseases Market Size During the Forecast Period?
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11929
What Are the High-Growth Segments in the Cardiometabolic Diseases Market?
The cardiometabolic diseases market covered in this report is segmented -
1) By Type: Chronic Or Congestive Heart Failure, Hypertension, Type 2 Diabetes, Obesity
2) By Treatment: ACE inhibitors, Diuretics, Glucophage, Liposuction, Other Treatments
3) By Dosage: Tablet, Injection
4) By Route Of Administration: Oral, Intravenous, Other Routes Of Administration
5) By End-Users: Clinic, Hospital, Other End-Users
Subsegments:
1) By Chronic Or Congestive Heart Failure: Systolic Heart Failure, Diastolic Heart Failure
2) By Hypertension: Primary Hypertension, Secondary Hypertension
3) By Type 2 Diabetes: Insulin Resistance, Impaired Glucose Tolerance
4) By Obesity: Class I Obesity (BMI 30-34.9), Class II Obesity (BMI 35-39.9), Class III Obesity (BMI 40 And above)
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11929&type=smp
What Key Drivers Are Expected to Influence Future Cardiometabolic Diseases Market Growth?
The surge in the incidence of obesity is anticipated to fuel the expansion of the cardiometabolic disease market in the future. Defined by excess body fat that results in increased body weight, obesity is a multifaceted disorder that directly impacts the prevalence of cardiovascular risk factors such as hypertension, type 2 diabetes, sleep disorders, and dyslipidemia. For example, the World Health Organization (WHO), a Switzerland-based international organization, reported in March 2022 that over one billion people worldwide suffer from obesity, which includes 340 million adolescents, 650 million adults, and 39 million children annually. The WHO projects that by 2025, 167 million adults and children will suffer health setbacks due to overweight or obesity. Consequently, the high rate of obesity is catalyzing the rise of the cardiometabolic diseases market.
Which Companies Hold the Largest Share Across Different Cardiometabolic Diseases Market Segments?
Major companies operating in the cardiometabolic diseases market include Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi SA, Kowa Company Ltd., Thermo Fisher Scientific, Abbott Laboratories, Takeda Pharmaceutical Company, Eli Lilly and Company, Novo Nordisk A/S, Siemens Healthineers, Boehringer Ingelheim International GmbH, Becton, Dickinson and Company, Stryker Corporation, AstraZeneca Plc, Viatris Inc., Biocrates Life Sciences AG, Boston Scientific, Astellas Pharma Inc., Terumo Corporation, Agilent Technologies, Edwards Lifesciences, Bruker Corporation, Alnylam Pharmaceuticals Inc., Arrowhead Pharmaceuticals Inc., Cardax Inc.
What Trends Are Driving Growth in The Cardiometabolic Diseases Market?
Embracing cutting-edge technologies is a key trend that is becoming increasingly common in the cardiometabolic diseases market. Firms involved in this sector are resorting to unique technologies to maintain their market position. For example, in February 2023, Eko Health Inc., an American company that creates digital health technologies for the detection of heart and lung diseases, unveiled the Sensora cardiac disease detection platform. This platform leverages artificial intelligence (AI) to reliably detect structural murmurs, symptoms of valvular heart disease (VHD), and care pathway analytics software that offers metrics and insight into the patient's journey through the healthcare sector. This digital stethoscope can record and analyze heartbeats and electrical impulses.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/cardiometabolic-diseases-global-market-report
What Are the Emerging Geographies for The Cardiometabolic Diseases Market Growth?
North America was the largest region in the cardiometabolic diseases market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiometabolic diseases market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Cardiometabolic Diseases Market?
2. What is the CAGR expected in the Cardiometabolic Diseases Market?
3. What Are the Key Innovations Transforming the Cardiometabolic Diseases Industry?
4. Which Region Is Leading the Cardiometabolic Diseases Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising Obesity Rates Fuel Growth In Cardiometabolic Disease Market: Key Factor Driving The Growth In The Cardiometabolic Diseases Market here
News-ID: 3997469 • Views: …
More Releases from The Business Research Company
Trends in Growth, Segment Analysis, and Competitive Strategies Influencing the M …
The meal replacement market is gaining significant momentum as consumer preferences shift toward convenient and health-focused nutrition solutions. With rising awareness about preventive healthcare and personalized diets, this sector is set for considerable expansion. Let's explore how the market size is expected to evolve, who the key players are, emerging trends, and the main segments driving this growth.
Projected Growth Trajectory of the Meal Replacement Market Size
The meal replacement…
Leading Companies Reinforcing Their Presence in the Malted Barley Market
The malted barley industry is positioned for steady expansion as demand grows across various sectors. With increasing interest from craft brewers and functional food producers, this market is set to experience meaningful growth driven by innovation and sustainability efforts. Let's dive into the current market size, key players shaping the industry, trends influencing its trajectory, and detailed segment insights.
Projected Market Size and Growth Outlook of the Malted Barley Market …
Future Perspective: Key Trends Shaping the Low-calorie Food Market up to 2030
The low-calorie food market is poised for significant expansion as consumer preferences shift toward healthier eating habits and more personalized nutrition options. Advances in product innovation and supportive regulatory frameworks are expected to drive rapid growth over the coming years. Here's an overview of the market size, key players, emerging trends, and segmentation shaping this evolving industry.
Projected Expansion of the Low-calorie Food Market Size Through 2030
The low-calorie food…
Competitive Landscape: Leading Companies and New Entrants in the Liquid Nutritio …
The liquid nutritional supplement sector is on the rise, driven by evolving consumer preferences and innovations in health and wellness. With growing awareness about personalized nutrition and preventive healthcare, this market is set to witness substantial growth over the coming years. Let's explore the market's projected size, major players, emerging trends, and key segments shaping this dynamic industry.
Projected Market Value and Growth Trajectory of the Liquid Nutritional Supplement Market …
More Releases for Cardiometabolic
Cardiometabolic Disease Market to Reach $60.81B by 2035
Cardiometabolic Disease Market Poised for Steady Growth Amid Rising Global Health Concerns
Tackling the Global Cardiometabolic Health Crisis
Cardiometabolic diseases-including obesity, type 2 diabetes, hypertension, and chronic heart failure-represent a major global health challenge, contributing to morbidity, mortality, and escalating healthcare costs. These interlinked conditions share common risk factors such as sedentary lifestyle, unhealthy diets, and aging populations, creating a pressing need for effective preventive and therapeutic interventions.
The global cardiometabolic disease market…
Rising Obesity Rates Fuel Growth In Cardiometabolic Disease Market: Powering Inn …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Cardiometabolic Diseases Market Through 2025?
The valuation of the cardiometabolic diseases sector has experienced consistent expansion over the last several years, projected to climb from $111.64 billion in 2024 up to $115.27 billion the following year, reflecting a 3.3% compound annual growth…
Charting a New Era in Cardiometabolic Care: The Global Cardiometabolic Drug Mark …
In an era defined by rising rates of obesity, diabetes, and cardiovascular disease, the global cardiometabolic drug market has emerged as a cornerstone of modern healthcare. Spanning therapies for type 2 diabetes, dyslipidemia, hypertension, and related metabolic disorders, this market is not only addressing some of the world's most pressing health challenges but is also redefining standards of patient care through precision targeted medicines, innovative delivery systems, and breakthrough combination…
Cardiometabolic Diseases Market Embraces Advanced Solutions Trend: A Crucial Inf …
What industry-specific factors are fueling the growth of the cardiometabolic diseases market?
The cardiometabolic disease market is projected to grow due to the anticipated rise in obesity rates. Being a multifaceted disorder, obesity is identified by an overly excessive accumulation of fat in the body, resulting in increased body weight. This directly impacts the occurrence of cardiovascular risk determinants such as dyslipidemia, type 2 diabetes, hypertension, and sleep disorders. For example,…
Cardiometabolic Diseases Market Analysis & Opportunities 2024-2033
"The Business Research Company recently released a comprehensive report on the Global Cardiometabolic Diseases Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample…
Cardiometabolic Disease Market: A Comprehensive Analysis
Introduction
In 2023, the global cardiometabolic disease market boasted a substantial valuation of USD 111 billion, and its growth trajectory continues to impress with a projected Compound Annual Growth Rate (CAGR) of 3.8% from 2024 to 2032, potentially reaching an astounding value of USD 155.9 billion by 2032. This upward surge is underpinned by a web of interconnected factors, including the worldwide clamor for healthier lifestyles, the alarming escalation of fast…
